Going Public: Psychedelics Execs Talk Opportunities and Challenges

Stock Information for HAVN Life Sciences

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About HAVN Life Sciences

Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Provides Comprehensive Investor Update
Psyched Wellness Announces Appointment of New Director and Resignation of a Director
Psyched Wellness Announces Supply Chain Disruption in the US
Psyched Wellness Adds Harmons to List of Retail Partners, Engages UNFI For Distribution, and Announces Appointment of Kyle Nazareth as Chief Financial Officer
Psyched Wellness Developing Amanita Muscaria Gummies for Sale in the USA
Psyched Wellness Announces Grant of Options
Psyched Wellness Closes Final US$2.5M Tranche of Its Non-Brokered Private Placement for a Total of US$7.5M with Gotham Green Partners and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.